Livermore

KALA BIO, Inc.

KALA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001479419

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Oct 24, 2025Oct 22, 2025Kharabi DariusCHIEF BUSINESS OFFICERSSaleCommon Stock−20.81K$0.83−$17.27K41.76K−33.3%SEC
Oct 24, 2025Oct 22 – Oct 23, 2025Reumuth MaryCHIEF FINANCIAL OFFICERSSaleCommon Stock−33.2K$0.8297−$27.54K28.91K−53.5%SEC
Oct 24, 2025Oct 22, 2025Bazemore ToddDirectorSSaleCommon Stock−47.77K$0.83−$39.65K35.93K−57.1%SEC
Oct 24, 2025Oct 23, 2025Iwicki Mark TDirectorSSaleCommon Stock−154.89K$0.81−$125.46K103.54K−59.9%SEC
Oct 24, 2025Oct 22, 2025Brazzell Romulus KSEE REMARKSSSaleCommon Stock−46.75K$0.83−$38.8K35.95K−56.5%SEC
Oct 2, 20254:47 PM ETSep 30 – Oct 1, 2025BAKER JULIAN and 3 othersOther: Former 10% ownerSSaleCommon Stock−730.41K$1.4468−$1.06M425.01K−63.2%SEC
Jun 26, 2025Jun 24, 2025Kharabi DariusCHIEF BUSINESS OFFICERSSaleCommon Stock−4.51K$4.01−$18.09K62.57K−6.7%SEC
Jun 26, 2025Jun 24, 2025Reumuth MaryCHIEF FINANCIAL OFFICERSSaleCommon Stock−3.63K$4.01−$14.56K62.1K−5.5%SEC
Jun 26, 2025Jun 24, 2025Bazemore ToddSEE REMARKSSSaleCommon Stock−4.06K$4.01−$16.27K83.7K−4.6%SEC
Jun 26, 2025Jun 24, 2025Brazzell Romulus KSEE REMARKSSSaleCommon Stock−5.25K$4.01−$21.06K82.7K−6.0%SEC
Jun 26, 2025Jun 24, 2025Iwicki Mark TDirectorSSaleCommon Stock−13.23K$4.01−$53.04K258.43K−4.9%SEC
Jun 5, 2025AmendedJun 3, 2025Iwicki Mark TDirectorSSaleCommon Stock−10.87K$3.74−$40.64K269.21K−3.9%SEC
Jun 4, 2025Jun 3, 2025Kharabi DariusCHIEF BUSINESS OFFICERSSaleCommon Stock−730$3.74−$2.73K67.08K−1.1%SEC
Jun 4, 2025Jun 3, 2025Reumuth MaryCHIEF FINANCIAL OFFICERSSaleCommon Stock−2.85K$3.74−$10.66K65.73K−4.2%SEC
Jun 4, 2025Jun 3, 2025Bazemore ToddSEE REMARKSSSaleCommon Stock−3.39K$3.74−$12.68K87.76K−3.7%SEC
Jun 4, 2025Jun 3, 2025Brazzell Romulus KSEE REMARKSSSaleCommon Stock−3.69K$3.74−$13.79K87.95K−4.0%SEC
Jan 7, 20258:14 PM ETJan 6, 2025Bazemore ToddSEE REMARKSSSaleCommon Stock−1.99K$7.63−$15.21K––SEC
Jan 7, 2025Jan 6, 2025Kharabi DariusCHIEF BUSINESS OFFICERSSaleCommon Stock−2.02K$7.63−$15.42K67.81K−2.9%SEC
Jan 7, 2025Jan 6, 2025Iwicki Mark TCHIEF EXECUTIVE OFFICERSSaleCommon Stock−5.78K$7.63−$44.09K280.08K−2.0%SEC
Jan 7, 2025Jan 6, 2025Reumuth MaryCHIEF FINANCIAL OFFICERSSaleCommon Stock−1.71K$7.63−$13.02K68.58K−2.4%SEC
Dec 31, 20244:00 PM ETDec 30, 2024BAKER JULIAN and 3 others10% OwnerPPurchaseCommon Stock+310.56K$6.44+$2M1.08M+40.2%SEC
Jun 27, 2024Jun 26, 2024Bazemore ToddSEE REMARKSSSaleCommon Stock−4.65K$4.75−$22.1K83.04K−5.3%SEC
Jun 27, 2024Jun 26, 2024Kharabi DariusCHIEF BUSINESS OFFICERSSaleCommon Stock−5.16K$4.75−$24.5K59.73K−7.9%SEC
Jun 27, 2024Jun 26, 2024Reumuth MaryCHIEF FINANCIAL OFFICERSSaleCommon Stock−4.16K$4.75−$19.77K60.19K−6.5%SEC
Jun 27, 2024Jun 26, 2024Iwicki Mark TCHIEF EXECUTIVE OFFICERSSaleCommon Stock−15.17K$4.75−$72.05K263.76K−5.4%SEC
Jun 27, 2024Jun 26, 2024Brazzell Romulus KSEE REMARKSSSaleCommon Stock−5.49K$4.75−$26.07K83.98K−6.1%SEC
Jun 3, 2024May 31, 2024Bazemore ToddSEE REMARKSSSaleCommon Stock−2.09K$6.09−$12.75K87.69K−2.3%SEC
Jun 3, 2024May 31, 2024Kharabi DariusCHIEF BUSINESS OFFICERSSaleCommon Stock−231$6.09−$1.41K64.89K−0.4%SEC
Jun 3, 2024May 31, 2024Reumuth MaryCHIEF FINANCIAL OFFICERSSaleCommon Stock−1.79K$6.09−$10.88K64.35K−2.7%SEC
Jun 3, 2024May 31, 2024Brazzell Romulus KSEE REMARKSSSaleCommon Stock−2K$6.09−$12.19K89.47K−2.2%SEC
Jun 3, 2024May 31, 2024Iwicki Mark TCHIEF EXECUTIVE OFFICERSSaleCommon Stock−7.39K$6.09−$45.02K278.92K−2.6%SEC
Jan 5, 20244:03 PM ETJan 4, 2024Bazemore ToddSEE REMARKSSSaleCommon Stock−1.41K$6.74−$9.47K––SEC
Jan 5, 2024Jan 4, 2024Trachtenberg EricSEE REMARKSSSaleCommon Stock−1.23K$6.74−$8.27K68.07K−1.8%SEC
Jan 5, 2024Jan 4, 2024Kharabi DariusCHIEF BUSINESS OFFICERSSaleCommon Stock−1.39K$6.73−$9.32K65.12K−2.1%SEC
Jan 5, 2024Jan 4, 2024Brazzell Romulus KSEE REMARKSSSaleCommon Stock−1.62K$6.74−$10.9K91.47K−1.7%SEC
Jan 5, 2024Jan 4, 2024Iwicki Mark TCHIEF EXECUTIVE OFFICERSSaleCommon Stock−4.54K$6.73−$30.55K286.32K−1.6%SEC
Jan 5, 2024Jan 4, 2024Reumuth MaryCHIEF FINANCIAL OFFICERSSaleCommon Stock−1.23K$6.74−$8.27K66.14K−1.8%SEC
Jan 6, 2023Jan 4, 2023Trachtenberg EricSEE REMARKSSSaleCommon Stock−60$28.55−$1.71K11.5K−0.5%SEC
Jan 6, 2023Jan 4, 2023Reumuth MaryCHIEF FINANCIAL OFFICERSSaleCommon Stock−60$28.54−$1.71K11.88K−0.5%SEC
Jan 6, 2023Jan 4, 2023Brazzell Romulus KSEE REMARKSSSaleCommon Stock−73$28.53−$2.08K18.54K−0.4%SEC
Jan 6, 2023Jan 4, 2023Bazemore ToddSEE REMARKSSSaleCommon Stock−62$28.54−$1.77K14.84K−0.4%SEC
Jan 6, 2023Jan 4, 2023Iwicki Mark TCHIEF EXECUTIVE OFFICERSSaleCommon Stock−198$28.54−$5.65K45.97K−0.4%SEC
Oct 28, 2022Oct 26, 2022Trachtenberg EricSEE REMARKSSSaleCommon Stock−194$6.52−$1.26K2.03K−8.7%SEC
Oct 28, 2022Oct 26, 2022Bazemore ToddSEE REMARKSSSaleCommon Stock−214$6.51−$1.39K2.1K−9.3%SEC
Oct 28, 2022Oct 26, 2022Reumuth MaryCHIEF FINANCIAL OFFICERSSaleCommon Stock−194$6.51−$1.26K2.42K−7.4%SEC
Oct 28, 2022Oct 26, 2022Brazzell Romulus KSEE REMARKSSSaleCommon Stock−261$6.51−$1.7K5.81K−4.3%SEC
Oct 28, 2022Oct 26, 2022Iwicki Mark TCHIEF EXECUTIVE OFFICERSSaleCommon Stock−561$6.52−$3.66K4.46K−11.2%SEC
Jun 29, 20228:12 PM ETJun 27, 2022Trachtenberg EricSEE REMARKSSSaleCommon Stock−2.61K$0.37−$966.81111.2K−2.3%SEC
Jun 29, 20228:12 PM ETJun 27, 2022Reumuth MaryCHIEF FINANCIAL OFFICERSSaleCommon Stock−2.61K$0.37−$966.81130.6K−2.0%SEC
Jun 29, 20228:11 PM ETJun 27, 2022Brazzell Romulus KSEE REMARKSSSaleCommon Stock−3.14K$0.37−$1.16K285.2K−1.1%SEC